Oncology CRO Email us info@sms-oncology.com
Follow us on

The 4D oncology CRO

Drug – Data – Dossier

The path to successful development of oncology drugs is geared by generation of clinical data that builds up a compliant regulatory dossier. Oncology drug development is complex and direction is required to navigate a safe passageway by avoiding risks and leveraging opportunities to increase the chances of success.


SMS-oncology adds an extra dimension to clinical cancer research by providing direction to our sponsors. During the study we turn complex data into meaningful insights using our oncology expertise. This information helps our sponsors to make informed decisions, stay in control, mitigate risks, identify opportunities and collect the right data to build the regulatory dossier. SMS-oncology: an oncology CRO adding value by providing direction.

Our oncology services

Clinical operations Read more

Clinical operations

From initiation and implementation to completion of oncology clinical trials with a specialization in:
• Early phase oncology trials
• Immuno-oncology trials

Consultancy Read more


From strategic expert advice on oncology drug development and trial design to protocol writing and scientific advisory boards.

Integrated services Read more

Integrated services

From upfront strategic advice translated into clinical operations to frequent meaningful insights during study conduct.

Our advantages

Responsiveness, Quality & Flexibility
  • Responsive and "right-sized" project teams for close collaboration, flexibility and fast-decision making
  • Close and personal involvement of the management team ensuring a high standard of quality
  • Delivering tailor made solutions by offering full or functional services as needed
Oncology Experts
  • In-depth knowledge of the complex nature of early phase oncology and immuno-oncology studies
  • Dedicated professionals with oncology know-how and experience in all functions of the company
  • Extensive network of Key Opinion Leaders throughout Europe
  • Proactively addressing challenges before they turn into hurdles
  • Strategic clinical development advice that can be directly translated into clinical operations
  • Turning complex data into meaningful insights during study conduct using our oncology expertise


15 January 2016

We are pleased to report that 2015 was a great year for SMS-oncology achieving a strong growth, see press release. We are proud of last years’ implementation and improvement of (new) services and processes throughout the corporate framework underpinning the achievement.

14 January 2016

SMS-oncology will start its Oncology Clinical Research Associate (CRA) Academy as of April 1, 2016, offering graduates the perfect stepping stone to start their career in clinical cancer research. In a 3-month program you will receive comprehensive, individualized, hands-on training to become an oncology CRA at SMS-oncology.

7 January 2015

Our latest newsletter Oncology Highlights December 2015 is online, providing you an excellent overview of oncology publications, industry news and drug approvals of last month.

Conference schedule

18 February 2016

Innovation for Health, Rotterdam, The Netherlands

9 March 2016

BioCapital Europe, Amsterdam, The Netherlands

4-6 April 2016

BIO-Europe Spring, Stockholm, Sweden

Recent blog posts

26 October 2015

SMS-oncology: Q, Q, Q!